John E Gallina
CIK 1433032 · EVP & Chief Financial Officer · last filed 2026-10-09
John E Gallina is an EVP & Chief Financial Officer who has filed 38 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for ARAI, was dated Oct 9, 2026. Across all open-market trades the lifetime net is −$36.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ANTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
INDIANAPOLIS, IN 46204
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAI | Director | 18,202 | $0.11 | $2.0K | $0 | 7 | 2026-10-09 |
| CVS | Director | 582 | $92.57 | $53.9K | $0 | 2 | 2026-05-15 |
| ELV | EVP & Chief Financial Officer | 63,725 | $432.93 | $27.59M | $0 | 1 | 2023-03-03 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 46,857 | $482.58 | $22.61M | -$24.09M | 9 | 2022-03-03 |
| ANTX | EVP & Chief Financial Officer | 40,510 | $3.54 | $143.4K | -$5.65M | 6 | 2018-03-07 |
| Elevance Health, Inc. (WLP) Delisted | SVP & Chief Accounting Officer | 22,490 | — | — | -$6.56M | 13 | 2014-03-05 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-09 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2026-07-07 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2026-05-15 | CVS | Grant (A) | — | $0 | EDGAR |
| 2026-04-02 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2026-03-20 | CVS | Grant (A) | +582 | $41.8K | EDGAR |
| 2026-01-05 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2025-10-20 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2025-10-08 | ARAI | Grant (A) | +7,292 | $0 | EDGAR |
| 2025-09-03 | ARAI | Grant (A) | +8,549 | $0 | EDGAR |
| 2023-03-03 | ELV | Mixed | +7,544 | -$2.46M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.